A Compelling Genetic Hypothesis for a Complex Disease: PRODH2 DGCR6 Variation Leads to Schizophrenia Susceptibility

Total Page:16

File Type:pdf, Size:1020Kb

A Compelling Genetic Hypothesis for a Complex Disease: PRODH2 DGCR6 Variation Leads to Schizophrenia Susceptibility Commentary A compelling genetic hypothesis for a complex disease: PRODH2͞DGCR6 variation leads to schizophrenia susceptibility Aravinda Chakravarti* McKusick–Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287 he human genome sequence is facili- lying genes have proved difficult and dis- cation of common sequence variation Ttating the task of identifying disease ease pathophysiology is still in doubt. within and outside the known genes, genes, understanding their normal func- Over the past three decades, scores of called single nucleotide polymorphisms. tions and why compromising their func- psychiatrists and geneticists have grappled Subsequently, to test whether any of the tion is associated with specific features of with identifying the genetic determinants variants were schizophrenia ‘‘markers’’ a disorder and its inheritance pattern (1). of schizophrenia, now universally thought the authors conducted two genetic tests: Genetic disorders with simple dominant to reside at multiple genes (8). These (i) Were the variants in increased fre- and recessive (Mendelian) patterns of in- genetic mapping studies have proved to be quency among schizophrenics as com- heritance are invariably caused by frustrating because no single chromo- pared with controls? (ii) Were the variants rare single-gene mutations that are somal region appears paramount and transmitted by parents to their affected both necessary and sufficient for the dis- genomic locations identified by one group children in significantly greater frequency ease to manifest. However, some single- have seldom been replicated by others. than expected? These genetic tests were gene disorders can display a complex There are many possible reasons for this conducted in three independent and well- pattern of inheritance. outcome, both biolog- documented samples of schizophrenia The prototype for ical and methodologi- cases. These tests led to one inescapable this class is fragile X cal, but heterogeneity The familial nature of conclusion: genetic variation in the 22q11 syndrome (2), whose in disease causation is region increased schizophrenia risk by non-Mendelian and schizophrenia does not conform thought to be the most 2-fold or more. complex pattern of to simple dominant or recessive likely cause. Although the proof is not absolute, the COMMENTARY X-linked inheritance One chromosomal data of Liu et al. (6) strongly suggest that modes of inheritance. arises from dynamic region that appears genetic variation in a specific gene, evolution of the muta- to be contributory to PRODH2, is the likely cause of schizo- tion within families schizophrenia suscep- phrenia susceptibility. The first line of (3). Thus, complexity in inheritance pat- tibility is that on human chromosome evidence comes from the observations terns is not inconsistent with single-gene 22q11 (9). Despite its inconsistent involve- that the strongest association, both by defects although geneticists routinely ment across mapping studies, its impor- elevated frequency and transmission, of equate the non-Mendelian nature of a tance is demonstrated by the finding that schizophrenia is with single nucleotide trait with inheritance at multiple genes 25–31% of patients with microdeletions of polymorphisms within this gene. The sec- (4). Genetic dissection of multigenic dis- chromosomal material at 22q11 met diag- ond piece of evidence is that most of the orders is truly challenging yet possible (5), nostic criteria for schizophrenia and asso- variants in PRODH2 associated with dis- particularly with the human genome se- ciated disorders. These microdeletions are ease are identical to sequences in the quence in hand. In an outstanding piece of rare in the general population but are 80 neighboring pseudogene. Third, in a small sleuthing, Maria Karayiorgou and col- times more frequent in adult schizophren- sample, carriers of variants associated leagues (6) now show that genetic varia- ics and 240 times elevated in childhood- with the disease show elevated plasma tion in proline dehydrogenase on human onset schizophrenia. Although childhood proline levels; it is difficult to know chromosome 22q11 is a likely and signif- onset of schizophrenia is rare, this marked whether brain proline levels are similarly icant cause of schizophrenia. elevation of microdeletion frequency is a affected. As in all studies of complex Schizophrenia is a common and severe terrific clue because it solidly implicates a disorders, caveats abound, but the evi- mental illness of thought, emotion, and genomic region, at least for some cases of dence for PRODH2 culpability in schizo- behavior that affects about 1% of the schizophrenia etiology. The specific genes phrenia is excellent and is more than general population. It is a devastating involved, however, remained a mystery, enough to deserve continued careful scru- disorder, probably unique to humans, af- until the present study (6), because the tiny. PRODH2 encodes proline dehydro- fecting not only the sufferers but also their deletions remove many genes (10). genase, a mitochondrial enzyme that families. The intense familiality of schizo- The success of the Liu et al. (6) study converts proline to ⌬1-pyrroline-5- phrenia has been recognized for a long clearly owes a great deal to the public carboxylate and is involved in transfer of time and siblings of schizophrenics have a availability of the human genome se- redox potential across the mitochondrial 10-fold elevated susceptibility to the phe- quence (11). The authors undertook the membrane. The gene is widely expressed notype (7). The familial nature of schizo- systematic screening of all known nine phrenia does not conform to simple dom- genes in a 1.5 million-bp interval defining inant or recessive modes of inheritance the schizophrenia ‘‘critical’’ interval (10). See companion article on page 3717 in issue 6 of volume 99. and, consequently, identifying the under- This screening involved first the identifi- *E-mail: [email protected]. www.pnas.org͞cgi͞doi͞10.1073͞pnas.092158299 PNAS ͉ April 16, 2002 ͉ vol. 99 ͉ no. 8 ͉ 4755–4756 Downloaded by guest on September 24, 2021 in many tissues, including in the brain, and should be the comprehensive screening of no functional consequences can, on occa- its homozygous deficiency, hyperproline- all genes in a region and the examination of sion, be copied into the functional gene mia, is an inborn error of metabolism. many single nucleotide polymorphisms. Al- and lead to disease (6). If proven, schizo- There is some indication that heterozy- though this is considerable work, even with phrenia, at least the PRODH2 variety, gous deficiency of PRODH2 may be a current genomics technology, Liu et al. (6) arises from the peculiarities of our ge- cause of isolated hyperprolinemia (12). were rewarded by finding multiple markers nome sequence and is a genomic disorder. Importantly, mice created to be homozy- associated with disease in two distinct tests. Thus, some of the complexities in inheri- gous for PRODH2 deficiency demonstrate A low-resolution screen always fails to dis- tance could arise from this feature. a deficit in prepulse inhibition (13), a mea- tinguish between the absence of an effect The recognition that sequence struc- sure of sensorimotor gating affected in and the failure to detect it. Many previous ture affects gene function and this schizo- schizophrenics. Finally, proline may serve as marker association studies in schizophrenia phrenia study could not have been at- a direct modulator of glutamatergic activity were doomed because they examined tempted in the absence of an accurate and in the brain. Thus, the evidence for candi- only one single nucleotide polymorphism finished reference genome sequence for dacy for PRODH2 de- per gene. Fifth, the human chromosome 22 (11). The finished ficiency in schizophre- study of an animal sequence clarifies the gene content and nia is considerable. model, even when it thus allows the systematic gene search The study by Liu et Liu et al. were rewarded by does not demonstrate a strategy. Thus, finishing the human ge- al. (6) is compelling for ‘‘disease’’ phenotype nome sequence remains a top priority. a variety of reasons and finding multiple markers but a biochemical and This is particularly so in the regions that is a wonderful example associated with disease in neural phenotype, is are difficult to finish because they contain of the power of genetic indispensable (13). two distinct tests. a greater frequency of sequence repeats studies in the human. An emerging idea This study has five fea- in human genetics is and duplications. Indeed, these regions tures that are important that of ‘‘genomic dis- may have a surfeit of complex disease to emphasize. First, there is incredible value orders’’ where the mutation results from genes. to clinical genetic studies of apparently rare the specific genomic structure, particu- Liu et al. (6) have raised as many ques- syndromes because they allow us to make larly duplications. This is particularly the tions as they have answered. Chief among cogent genetic hypothesis, such as defi- case with human chromosome 22, which is them is the contribution of PRODH2 to ciency of genetic material in 22q11 predis- extremely rich in segmental duplications schizophrenia risk in the population. Is pose to neuropsychiatric disease. Second, (14). PRODH2 is one example of such PRODH2 deficiency necessary and suffi- there is immense value to well-documented ‘‘paralogous’’ genes on
Recommended publications
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • DGCR6 at the Proximal Part of the Digeorge Critical Region Is Involved in Conotruncal Heart Defects
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Institutional Repository : the EHIME area OPEN Citation: Human Genome Variation (2015) 2, 15004; doi:10.1038/hgv.2015.4 © 2015 The Japan Society of Human Genetics All rights reserved 2054-345X/15 www.nature.com/hgv ARTICLE DGCR6 at the proximal part of the DiGeorge critical region is involved in conotruncal heart defects Wenming Gao1, Takashi Higaki1, Minenori Eguchi-Ishimae1, Hidehiko Iwabuki1, Zhouying Wu1, Eiichi Yamamoto2, Hidemi Takata1, Masaaki Ohta1, Issei Imoto3, Eiichi Ishii1 and Mariko Eguchi1 Cardiac anomaly is one of the hallmarks of DiGeorge syndrome (DGS), observed in approximately 80% of patients. It often shows a characteristic morphology, termed as conotruncal heart defects. In many cases showing only the conotruncal heart defect, deletion of 22q11.2 region cannot be detected by fluorescence in situ hybridization (FISH), which is used to detect deletion in DGS. We investigated the presence of genomic aberrations in six patients with congenital conotruncal heart defects, who show no deletion at 22q11.2 in an initial screening by FISH. In these patients, no abnormalities were identified in the coding region of the TBX1 gene, one of the key genes responsible for the phenotype of DGS. However, when copy number alteration was analyzed by high-resolution array analysis, a small deletion or duplication in the proximal end of DiGeorge critical region was detected in two patients. The affected region contains the DGCR6 and PRODH genes. DGCR6 has been reported to affect the expression of the TBX1 gene. Our results suggest that altered dosage of gene(s) other than TBX1, possibly DGCR6, may also be responsible for the development of conotruncal heart defects observed in patients with DGS and, in particular, in those with stand-alone conotruncal heart defects.
    [Show full text]
  • Network Effects of the Neuropsychiatric 15Q13.3 Microdeletion on the Transcriptome and Epigenome in Human Induced Neurons
    bioRxiv preprint doi: https://doi.org/10.1101/772541; this version posted September 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Network effects of the neuropsychiatric 15q13.3 microdeletion on the transcriptome and epigenome in human induced neurons Siming Zhang (B.S., Stanford University), Xianglong Zhang (Ph.D., Stanford University), Shining Ma (Ph.D., Stanford University), Carolin Purmann (Ph.D., Stanford University), Kasey Davis (Ph.D., Stanford University), Wing Hung Wong (Ph.D., Stanford University), Jonathan Bernstein (MD, Ph.D., Stanford University), Joachim Hallmayer (MD, Stanford University), Alexander E Urban (Ph.D., Stanford University) Corresponding author: Alexander E Urban Address: 3165 Porter Drive, Stanford CA 94304 Phone: (650) 736-9528, Fax: (650) 725-4913 email: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/772541; this version posted September 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Heterozygous deletions in the 15q13.3 region are associated with several neuropsychiatric disorders including autism, schizophrenia, and attention deficit hyperactivity disorder. Several genes within the 15q13.3 deletion region may play a role in neuronal dysfunction, based on association studies in humans and functional studies in mice, but the intermediate molecular mechanisms remain unknown.
    [Show full text]
  • Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
    Stem Cell Rev and Rep DOI 10.1007/s12015-016-9662-8 Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications Behnam Ahmadian Baghbaderani 1 & Adhikarla Syama2 & Renuka Sivapatham3 & Ying Pei4 & Odity Mukherjee2 & Thomas Fellner1 & Xianmin Zeng3,4 & Mahendra S. Rao5,6 # The Author(s) 2016. This article is published with open access at Springerlink.com Abstract We have recently described manufacturing of hu- help determine which set of tests will be most useful in mon- man induced pluripotent stem cells (iPSC) master cell banks itoring the cells and establishing criteria for discarding a line. (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Keywords Induced pluripotent stem cells . Embryonic stem Reports, 5(4), 647–659, 2015). In this manuscript, we de- cells . Manufacturing . cGMP . Consent . Markers scribe the detailed characterization of the two iPSC clones generated using this process, including whole genome se- quencing (WGS), microarray, and comparative genomic hy- Introduction bridization (aCGH) single nucleotide polymorphism (SNP) analysis. We compare their profiles with a proposed calibra- Induced pluripotent stem cells (iPSCs) are akin to embryonic tion material and with a reporter subclone and lines made by a stem cells (ESC) [2] in their developmental potential, but dif- similar process from different donors. We believe that iPSCs fer from ESC in the starting cell used and the requirement of a are likely to be used to make multiple clinical products. We set of proteins to induce pluripotency [3]. Although function- further believe that the lines used as input material will be used ally identical, iPSCs may differ from ESC in subtle ways, at different sites and, given their immortal status, will be used including in their epigenetic profile, exposure to the environ- for many years or even decades.
    [Show full text]
  • Unraveling the Genetic and Developmental Mysteries of 22Q11 Deletion Syndrome
    Review TRENDS in Molecular Medicine Vol.9 No.9 September 2003 383 Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome Hiroyuki Yamagishi1 and Deepak Srivastava2 1Department of Pediatrics, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan 2Departments of Pediatrics and Molecular Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Rm NA8.124, Dallas, TX 75390-9148, USA Birth defects occur in nearly 5% of all live births and are susceptibilities that predispose individuals to a variety the major cause of infant mortality and morbidity. of birth defects. Here, we review the recent advances that Despite the recent progress in molecular and develop- have begun to reveal the human genetic, developmental mental biology, the underlying genetic etiology of most biology and molecular biology underpinnings of this congenital anomalies remains unknown. Heterozygous common syndrome. deletion of the 22q11.2 locus results in the most com- mon human genetic deletion syndrome, known as Clinical features of 22q11DS DiGeorge syndrome, and has served as an entry to The clinical findings associated with del22q11 are highly understanding the basis for numerous congenital heart variable. Approximately 75% of patients with 22q11DS are and craniofacial anomalies, among many other defects. born with congenital heart defects (CHD), mainly of the Extensive human genetic analyses, mouse modeling cardiac outflow tract and aortic arch. Other common and studies of developmental molecular cascades features of 22q11DS include a characteristic facial involved in 22q11 deletion syndrome are revealing com- appearance, immunodeficiency from thymic hypoplasia, plex networks of signaling and transcriptional events velopharyngeal dysfunction with or without cleft palate, that are essential for normal embryonic development.
    [Show full text]
  • CREB-Dependent Transcription in Astrocytes: Signalling Pathways, Gene Profiles and Neuroprotective Role in Brain Injury
    CREB-dependent transcription in astrocytes: signalling pathways, gene profiles and neuroprotective role in brain injury. Tesis doctoral Luis Pardo Fernández Bellaterra, Septiembre 2015 Instituto de Neurociencias Departamento de Bioquímica i Biologia Molecular Unidad de Bioquímica y Biologia Molecular Facultad de Medicina CREB-dependent transcription in astrocytes: signalling pathways, gene profiles and neuroprotective role in brain injury. Memoria del trabajo experimental para optar al grado de doctor, correspondiente al Programa de Doctorado en Neurociencias del Instituto de Neurociencias de la Universidad Autónoma de Barcelona, llevado a cabo por Luis Pardo Fernández bajo la dirección de la Dra. Elena Galea Rodríguez de Velasco y la Dra. Roser Masgrau Juanola, en el Instituto de Neurociencias de la Universidad Autónoma de Barcelona. Doctorando Directoras de tesis Luis Pardo Fernández Dra. Elena Galea Dra. Roser Masgrau In memoriam María Dolores Álvarez Durán Abuela, eres la culpable de que haya decidido recorrer el camino de la ciencia. Que estas líneas ayuden a conservar tu recuerdo. A mis padres y hermanos, A Meri INDEX I Summary 1 II Introduction 3 1 Astrocytes: physiology and pathology 5 1.1 Anatomical organization 6 1.2 Origins and heterogeneity 6 1.3 Astrocyte functions 8 1.3.1 Developmental functions 8 1.3.2 Neurovascular functions 9 1.3.3 Metabolic support 11 1.3.4 Homeostatic functions 13 1.3.5 Antioxidant functions 15 1.3.6 Signalling functions 15 1.4 Astrocytes in brain pathology 20 1.5 Reactive astrogliosis 22 2 The transcription
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • REVIEW the 22Q11.2 Deletion Syndrome
    REVIEW The 22q11.2 deletion syndrome Hiroyuki Yamagishi Department of Pediatrics and Molecular Biology, University of Texas Southwestern Medical Center, TX, USA Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan (Receivedfor publicationon March27, 2002) Abstract. The 22q11.2 deletion syndrome (22q11DS) encompasses DiGeorge syndrome, velo-cardio facial syndrome and conotruncal anomaly face syndrome and is due to a microdeletion of chromosome 22q11.2. This is the most frequent known interstitial deletion found in human with an incidence of 1 in 4,000 live births. A large number of clinical findings have been reported in affected patients, including cardiac defects, characteristic facial features, thymic hypoplasia, cleft palate, hypoparathyroidism, learning difficulties and psychiatric disorders. A comprehensive evaluation and follow-up program is necessary for patients with 22q11DS. A striking aspect of the 22q11DS phenotype is its variability, the basis of which remains unclear, and no phenotype-genotype correlation has been made. The structures primarily affected in patients with 22q11DS are derivatives of the embryonic pharyngeal arches and pouches suggesting that haploinsufficiency of the gene(s) on the deleted region, spanning 2-3 Mb, is important in pharyngeal arch/pouch development. Extensive gene searches have been successful in identifying more than 30 genes in the deleted segment. Although standard positional cloning has failed to demonstrate a role for any of these genes in the syndrome, the use of experimental animal models and advanced genome manipulation technologies in mice have been providing an insight into the developmental role of some of these genes, including TBX1. In this review, the clinical features and management of patients with 22q11DS are integrated with our current understanding of the embryo logical and molecular basis of this syndrome, as presented at the 1235th Meeting of The Keio Medical Society.
    [Show full text]
  • Juvenile Rheumatoid Arthritis and Del(22Ql 1) Syndrome: a Non
    JMed Genet 1998;35:943-947 943 Juvenile rheumatoid arthritis and del(22ql 1) J Med Genet: first published as 10.1136/jmg.35.11.943 on 1 November 1998. Downloaded from syndrome: a non-random association Alain Verloes, Cynthia Curry, Mauricette Jamar, Christian Herens, Patricia O'Lague, James Marks, Pierre Sarda, Patricia Blanchet Abstract mal part of the long arm of chromosome 22, Del(22qll) is a common microdeletion encompassing in its phenotype Shprintzen syndrome with an extremely variable phe- velocardiofacial syndrome,' Takao conotruncal notype. Besides classical manifestations, anomalies face syndrome, DiGeorge anomaly,2 such as velocardiofacial (Shprintzen) or some instances of Opitz GBBB syndrome type DiGeorge syndromes, del(22ql 1) syn- 2,' and isolated outflow tract defects (such as drome may be associated with unusual but truncus arteriosus, tetralogy of Fallot, or inter- probably causally related anomalies that rupted aortic arch). The incidence could be as expand its phenotype and complicate its high as 1/3500 births. recognition. We report here three children The spectrum of clinical anomalies associ- with the deletion and a chronic, erosive ated with 22ql 1 monosomy is remarkably vari- polyarthritis resembling idiopathic cases able. Recently, juvenile rheumatoid arthritis ofjuvenile rheumatoid arthritis (JRA). (TRA) has been reported in association with Patient 1, born in 1983, initially pre- del(22ql 1) in five children.4 We report here sented with developmental delay, facial three further cases of this association, indicat- dysmorphism, velopharyngeal insuffi- ing that the presence of a JRA-like disorder ciency, and severe gastro-oesophageal re- may not be fortuitous, but rather causally flux requiring G tube feeding.
    [Show full text]
  • Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Fall 2010 Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Renuka Nayak University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Computational Biology Commons, and the Genomics Commons Recommended Citation Nayak, Renuka, "Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress" (2010). Publicly Accessible Penn Dissertations. 1559. https://repository.upenn.edu/edissertations/1559 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1559 For more information, please contact [email protected]. Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Abstract Genes interact in networks to orchestrate cellular processes. Here, we used coexpression networks based on natural variation in gene expression to study the functions and interactions of human genes. We asked how these networks change in response to stress. First, we studied human coexpression networks at baseline. We constructed networks by identifying correlations in expression levels of 8.9 million gene pairs in immortalized B cells from 295 individuals comprising three independent samples. The resulting networks allowed us to infer interactions between biological processes. We used the network to predict the functions of poorly-characterized human genes, and provided some experimental support. Examining genes implicated in disease, we found that IFIH1, a diabetes susceptibility gene, interacts with YES1, which affects glucose transport. Genes predisposing to the same diseases are clustered non-randomly in the network, suggesting that the network may be used to identify candidate genes that influence disease susceptibility.
    [Show full text]
  • Genetic Variation at the 22Q11 PRODH2 DGCR6 Locus Presents an Unusual Pattern and Increases Susceptibility to Schizophrenia
    Genetic variation at the 22q11 PRODH2͞DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia Hui Liu†, Simon C. Heath‡, Christina Sobin†, J. Louw Roos§, Brandi L. Galke†, Maude L. Blundell†, Marge Lenane¶, Brian Robertsonʈ, Ellen M. Wijsman**, Judith L. Rapoport¶, Joseph A. Gogos††, and Maria Karayiorgou†‡‡ †Human Neurogenetics Laboratory, The Rockefeller University, New York, NY 10021; ‡Memorial Sloan Kettering Cancer Center, New York, NY 10021; §Department of Psychiatry and Weskoppies Hospital, University of Pretoria, Pretoria 0083, Republic of South Africa; ¶Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892; ʈDepartment of Psychiatry and Valkenberg Hospital, University of Capetown, Capetown 7925, Republic of South Africa; **Division of Medical Genetics and Department of Biostatistics, University of Washington, Seattle, WA 98195; and ††College of Physicians and Surgeons, Department of Physiology and Cellular Biophysics, Center for Neurobiology and Behavior, Columbia University, New York, NY 10032 Communicated by David E. Housman, Massachusetts Institute of Technology, Cambridge, MA, December 26, 2001 (received for review September 25, 2001) The location of a schizophrenia susceptibility locus at chromosome region harbors genes that alone, or in combination, are causally 22q11 has been suggested by genome-wide linkage studies. Addi- implicated in schizophrenia in a certain proportion of patients. The tional support was provided by the observation of a higher-than- overwhelming majority of the 22q11 deletions are 3 Mb in size, expected frequency of 22q11 microdeletions in patients with schizo- whereas a smaller percentage (Ϸ8%) involve the same proximal Ϸ phrenia and the demonstration that 20–30% of individuals with breakpoint but a different distal breakpoint resulting in a smaller 22q11 microdeletions develop schizophrenia or schizoaffective dis- 1.5-Mb deletion (9, 10).
    [Show full text]